Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and BSC for Malignant Bowel Obstruction in Ovarian Cancer
NCT01083537Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Feb 2010
- Primary completion
- Jun 2012
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), Paclitaxel Micelles for Injection in malignant bowel obstruction (MBO), sponsored by University Health Network. Started Feb 2010; status: terminated.
02
Drugs
Cisplatin micelle injection (HA132)Paclitaxel Micelles for Injection
03
Conditions
malignant bowel obstruction (MBO)
Beyond the preview
Go deeper on NCT01083537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01083537.